These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25420838)

  • 1. CC genotype at rs12979860 of IL28B is associated with lower risk of new-onset diabetes after transplantation in adult patients with liver transplantation for hepatitis C cirrhosis.
    Duca AM; de la Fuente S; Citores MJ; Cuenca AB; Cisneros E; Escamilla N; Baños I; Vilches C; Cuervas-Mons V
    Transplant Proc; 2014 Nov; 46(9):3114-6. PubMed ID: 25420838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy.
    Eurich D; Boas-Knoop S; Bahra M; Neuhaus R; Somasundaram R; Neuhaus P; Neumann U; Seehofer D
    Transplantation; 2012 Mar; 93(6):644-9. PubMed ID: 22411462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
    de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
    Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.
    Cisneros E; Baños I; Citores MJ; Duca A; Salas C; Noblejas A; Cañizares M; Millán I; Cuervas-Mons V; Vilches C
    Transplantation; 2012 Aug; 94(3):275-80. PubMed ID: 22790387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
    Duarte-Rojo A; Veldt BJ; Goldstein DD; Tillman HL; Watt KD; Heimbach JK; McHutchison JG; Poterucha JJ; Vargas-Vorackova F; Charlton MR
    Transplantation; 2012 Jul; 94(2):197-203. PubMed ID: 22766768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
    Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
    J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation.
    Allam SR; Krüger B; Mehrotra A; Schiano T; Schröppel B; Murphy B
    PLoS One; 2013; 8(1):e54854. PubMed ID: 23382988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
    Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
    Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
    Lange CM; Moradpour D; Doehring A; Lehr HA; Müllhaupt B; Bibert S; Bochud PY; Antonino AT; Pascual M; Farnik H; Shi Y; Bechstein WO; Moench C; Hansmann ML; Sarrazin C; Lötsch J; Zeuzem S; Hofmann WP
    J Hepatol; 2011 Aug; 55(2):322-7. PubMed ID: 21147186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.
    Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
    Lim KB; Sima HR; Fiel MI; Khaitova V; Doucette JT; Chernyiak M; Ahmad J; Bach N; Chang C; Grewal P; Kim-Schluger L; Liu L; Odin J; Perumalswami P; Florman SS; Schiano TD
    World J Gastroenterol; 2015 May; 21(20):6236-45. PubMed ID: 26034358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
    Charlton MR; Thompson A; Veldt BJ; Watt K; Tillmann H; Poterucha JJ; Heimbach JK; Goldstein D; McHutchison J
    Hepatology; 2011 Jan; 53(1):317-24. PubMed ID: 21254179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.
    Veldt BJ; Duarte-Rojo A; Thompson AJ; Watt KD; Heimbach JK; Tillmann HL; Goldstein DD; McHutchison JG; Charlton MR
    Am J Transplant; 2012 Mar; 12(3):737-44. PubMed ID: 22300408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
    Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P
    Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.
    Biggins SW; Trotter J; Gralla J; Burton JR; Bambha KM; Dodge J; Brocato M; Cheng L; McQueen M; Forman L; Chang M; Kam I; Everson G; Spritz RA; Klintmalm G; Rosen HR
    J Hepatol; 2013 May; 58(5):969-76. PubMed ID: 23333445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism.
    Del Campo JA; Ampuero J; Rojas L; Conde M; Rojas A; Maraver M; Millán R; García-Valdecasas M; García-Lozano JR; González-Escribano MF; Romero-Gómez M
    Aliment Pharmacol Ther; 2013 Jan; 37(1):74-80. PubMed ID: 23121166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
    Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K
    Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].
    Pár A; Pár G; Tornai I; Szalay F; Várszegi D; Fráter E; Papp M; Lengyel G; Fehér J; Varga M; Gervain J; Schuller J; Nemes Z; Péterfi Z; Tusnádi A; Hunyady B; Haragh A; Szinku Z; Pálinkás L; Berki T; Vincze A; Kisfali P; Melegh B
    Orv Hetil; 2013 Aug; 154(32):1261-8. PubMed ID: 23916907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.
    Fateh A; Aghasadeghi MR; Keyvani H; Mollaie HR; Yari S; Hadizade Tasbiti AR; Ghazanfari M; Monavari SH
    Asian Pac J Cancer Prev; 2015; 16(5):1873-80. PubMed ID: 25773839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.